| Susan Haskell, | |
|
207 N Main St, Ainsworth, NE 69210-1353 | |
| (402) 387-1420 | |
| Not Available |
| Full Name | Susan Haskell |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 207 N Main St, Ainsworth, Nebraska |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1891164786 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | (* (Not Available)) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Susan Haskell, 207 N Main St, Ainsworth, NE 69210-1353 Ph: (402) 387-1420 | Susan Haskell, 207 N Main St, Ainsworth, NE 69210-1353 Ph: (402) 387-1420 |
News Archive
Use of the drug interferon as a long-term maintenance strategy to slow the progression of liver disease associated with the hepatitis C virus is ineffective, UT Southwestern Medical Center researchers and their colleagues from nine other institutions have found in a multicenter study.
The U.S. Green Building Council has awarded the Orthopedic Building at Rush University Medical Center Gold Leadership in Energy and Environmental Design (LEED) certification. LEED is an internationally recognized green building certification system and the nationally accepted benchmark for the design, construction and operation of high performance green buildings.
Mothers who breastfeed for a total of at least 15 months over one or more pregnancies may be less likely to develop multiple sclerosis (MS) compared with those who don't breastfeed at all or do so for up to four months, according to a study published in the July 12, 2017, online issue of Neurology, the medical journal of the American Academy of Neurology.
A new drug candidate has been discovered by the University of South Australia to treat the most lethal form of brain cancer - glioblastoma - which kills 95 per cent of patients within five years.
Roche NimbleGen is pleased to announce that imaGenes GmbH, located in Berlin, Germany, has passed the certification process to qualify as a Roche NimbleGen Certified Service Provider for DNA Methylation Analysis. imaGenes is a solution provider for functional genomics and proteomics with a comprehensive portfolio of high-quality services for molecular life sciences.
› Verified 1 days ago
Mrs. Kimberly Buckendahl, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 207 N Main St, Ainsworth, NE 69210 Phone: 402-387-1420 | |
Ms. Melissa Ann Rowan, MS-CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 207 N Main St, Ainsworth, NE 69210 Phone: 402-387-1420 | |
Shawnee Latimer, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 207 N Main St, Ainsworth, NE 69210 Phone: 402-387-1420 | |
Tylee Schroeder, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 207 N Main St, Ainsworth, NE 69210 Phone: 402-387-1420 | |
Jordan Maurer, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 207 N Main St, Ainsworth, NE 69210 Phone: 402-387-1420 | |
Maggie Alderson, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 207 N Main St, Ainsworth, NE 69210 Phone: 402-387-1420 |